Catalyst OrthoScience Announces Todd Wilson, PhD as Vice President of Medical Education and Training
May 18, 2022
NAPLES, Fla.–(BUSINESS WIRE)–Catalyst OrthoScience, a medical device company focused on the upper extremity orthopedics market, is pleased to announce that Dr. Todd Wilson has joined Catalyst as Vice President of Medical Education and Training effective immediately.
“We are excited to have an executive with Todd’s experience join our team at Catalyst OrthoScience,” said Catalyst OrthoScience CEO and President Carl O’Connell. “As we continue to grow and establish our presence as an emerging global leader in shoulder pathology solutions, Todd’s leadership, experience, and passion for education will help make that vision a reality.”
“I am thrilled to join the Catalyst team at such a pivotal point in the company’s history and contribute to the vision of disrupting the usual approaches to shoulder replacement surgery by delivering innovative treatment solutions based on AO principles that make orthopedic surgery less invasive and more efficient for surgeons’ to deliver superior patient outcomes,” said Dr. Todd Wilson. “My driving force is to exceed expectations by building a world-class medical education and training program with the establishment of the Catalyst Center of Excellence to serve as our foundation for growth and transformation.”
Todd brings more than two decades experience delivering highly innovative world-class training and development programs which have transformed and positioned medical device and higher education organizations to support significant growth in his leadership roles with Capella University, Xtant Medical, Wright Medical, NuVasive, Orthofix, and most recently, Paragon 28.
Todd earned a PhD in Global Leadership from Indiana Institute of Technology and holds an MBA from Indiana Wesleyan University, to include bachelor’s degrees in Human Biology and Exercise Science from Indiana University.
About Catalyst OrthoScience Inc.
Catalyst OrthoScience is disrupting the usual approaches to shoulder replacement surgery. The Archer™ CSR Total Shoulder System is unique, offering precision and accuracy in shoulder restoration while preserving the patient’s bone and soft tissue. The Archer™ R1 Reverse Shoulder System is a single-tray arthroplasty system that offers surgeon-targeted implant positioning, a streamlined and versatile system, and bone sparing implants. Catalyst OrthoScience’s goal is to develop innovative medical solutions that make orthopedic surgery less invasive and more efficient for both surgeons and patients.
The company has a growing portfolio of patents and pending patents on its distinctive surgical offerings. Headquartered in Naples, Fla., Catalyst products are available across the U.S. For more information, visit www.CatalystOrtho.com.
Contacts
Carl O’Connell
CEO and President
Catalyst OrthoScience
239-325-9976
